Replies to post #284244 on Amarin Corp Plc (AMRN)

[zmanindc]

If that’s the case as the CEO he takes responsibility for the legal strategy of filing in the 9th circuit which is a crap shoot. In addition, he takes responsibility for the legal that lost. Some of the weakness in the legal strategy provided the means to rob us but his job, and only job of a public company is shareholder value. Where was the ROW strategy? As we waited for reduce-it his job was to set-up secondary markets. I do realize he played out all the hurdles to get the most for the company, label plus patents. When you are strong the challenger is more likely to settle. H&R along with what I believe a few hedge funds thought Amarin weak and took it all the way as they plan to do now. Worst case for them is a loss and the Teva deal. JT did not build out the markets and never truly gained wall street confidence. If he had this would not have happened.

[massulo52]

He was in the back room reading Penthouse and counting his pennies.

[Will Lar]

GIA!

Amarin is a single drug company without R&D, pipeline, manufacturer facilities & capabilities. Even its clinical research and trials are largely contracted out. The only assets that it has are labeling (the most valuable one), patent portfolio (oops!) and supplier contracts (value pending the terms). And if you want, let's throw the workforce (including all the newbie salespeople) to the pile. That's it!

And it's trying to tackle a VERY mature market - CVD, crowded with many options and dominated by the biggest of the big pharmas.

GIA in this case is like taking a knife to a gun fight. Seriously?!